Amneal Pharmaceuticals Plans $240 Million Manufacturing Expansion in Piscataway, New Jersey

The New Jersey Economic Development Authority (NJEDA) announced on October 26, 2026 that its board approved approximately $60 million in tax credits to support a planned manufacturing expansion by Amneal Pharmaceuticals in Piscataway, New Jersey.

330+ new jobs

The project represents more than $240 million in eligible capital investment over three years and is expected to create more than 330 new full-time jobs. Amneal qualifies for an award of $60.56 million over five years under the Next New Jersey Manufacturing Program.

An integrated eight-building campus

The expansion includes the renovation of eight buildings that will operate as a single, integrated manufacturing campus supporting production, quality control and logistics. It will expand manufacturing capabilities for transdermal patches, biosimilars and pharmaceutical injectables.

Amneal Co-CEOs Chirag Patel and Chintu Patel said:

“New Jersey is where Amneal began, and it remains central to our growth and our commitment to patients.”